Source: http://feedproxy.google.com/~r/HealthBusinessBlog/~3/VISq0kvyOjg/
Monday, 7 February 2011
Genentech serves as whipping boy again on Avastin/Lucentis
The New York Times headline Genentech Offers Secret Rebates for Eye Drug slams the company for offering physicians incentives to use Lucentis for wet age related macular degeneration instead of Avastin. They talk about a “confidential document,” find a doctor to accuse Genentech of “bribery” for running the program and quote a Senator to complain [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment